Pregnancy outcomes following exposure to onabotulinumtoxinA

Purpose To evaluate pregnancy outcomes following onabotulinumtoxinA (US Food and Drug Administration pregnancy category C product) exposure using the Allergan safety database. Methods The Allergan Global Safety Database contains reports of onabotulinumtoxinA administration before/during pregnancy, i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacoepidemiology and drug safety 2016-02, Vol.25 (2), p.179-187
Hauptverfasser:	Brin, Mitchell F., Kirby, Russell S., Slavotinek, Anne, Miller-Messana, Mary Ann, Parker, Lori, Yushmanova, Irina, Yang, Huiying
Format:	Artikel
Sprache:	eng
Schlagworte:	Abnormalities, Drug-Induced - diagnosis Abnormalities, Drug-Induced - epidemiology Abortion, Spontaneous - chemically induced Abortion, Spontaneous - diagnosis Abortion, Spontaneous - epidemiology Acetylcholine Release Inhibitors - adverse effects Adult Adverse Drug Reaction Reporting Systems - trends Birth defects Botulinum Toxins, Type A - adverse effects Databases, Factual - trends Drug therapy Female fetal defects Humans Live Birth - epidemiology Miscarriage onabotulinumtoxinA Original Report Original Reports pharmacoepidemiology Pharmacology Pregnancy Pregnancy Outcome - epidemiology Prenatal Exposure Delayed Effects - chemically induced Prenatal Exposure Delayed Effects - diagnosis Prenatal Exposure Delayed Effects - epidemiology Prospective Studies Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!